Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment

被引：23
|
作者：
Crocq, MA [1 ]
Leclercq, P [1 ]
Guillon, MS [1 ]
Bailey, PE [1 ]
机构：
[1] Ctr Hosp, F-68250 Rouffach, France
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷 / 05期
关键词：
olanzapine; obsessive-compulsive disorder; augmentation therapy; treatment-unresponsive OCD;
D O I：
10.1016/S0924-9338(02)00673-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：296 / 297
页数：2
相关论文
共 50 条
  • [1] Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study
    Pfanner, C
    Marazziti, D
    Dell'Osso, L
    Presta, S
    Gemignani, A
    Milanfranchi, A
    Cassano, GB
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (05) : 297 - 301
  • [2] Venlafaxine open-label treatment of patients with obsessive-compulsive disorder
    Sevincok, L
    Uygur, B
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2002, 36 (06): : 817 - 817
  • [3] Open-Label Study of Duloxetine for the Treatment of Obsessive-Compulsive Disorder
    Dougherty, Darin D.
    Corse, Andrew K.
    Chou, Tina
    Duffy, Amanda
    Arulpragasam, Amanda R.
    Deckersbach, Thilo
    Jenike, Michael A.
    Keuthen, Nancy J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (02): : 1 - 4
  • [4] Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: An open-label case series
    Weiss, EL
    Potenza, MN
    McDougle, CJ
    Epperson, CN
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (08) : 524 - 527
  • [5] Naltrexone in Obsessive-Compulsive Disorder: an Open-Label Trial
    Hamidi, Aram
    Jahanguiri, Bijan
    Esfahani, Mehdi Nasr
    Dadfar, Mahbuobeh
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2007, 1 (01) : 16 - 21
  • [6] Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder
    Rosenberg, DR
    Stewart, CM
    Fitzgerald, KD
    Tawile, V
    Carroll, E
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (09): : 1180 - 1185
  • [7] Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder
    Potenza, MN
    Wasylink, S
    Longhurst, JG
    Epperson, CN
    McDougle, CJ
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (05) : 423 - 424
  • [8] Olanzapine treatment of obsessive-compulsive disorder
    Degner, D
    Bleich, S
    Kornhuber, J
    Rüther, E
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2000, 45 (04): : 393 - 393
  • [9] Open-label trial of paroxetine in children with obsessive-compulsive disorder
    Diler, RS
    Avci, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (10): : 706 - 719
  • [10] An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder
    Bakhla, Ajay Kumar
    Vijay
    Soren, Subhas
    Sarkhel, Sujit
    Choudhury, Suprakash
    INDIAN JOURNAL OF PSYCHIATRY, 2013, 55 (05) : S118 - S119
12345